Platelet Function Tests and Coronary Heart Disease

  • A. Strano
  • G. Davì
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 164)


It is well known that the formation of a platelet aggregate is the first step in an arterial thrombotic process.


Acute Myocardial Infarction Platelet Aggregation Platelet Factor Coronary Spasm Platelet Function Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R.S. Lees, A.C.A. Carvalho, Hypercholesterolemia and platelets. Adv. Exp. Med. Biol. 104:301 (1978).PubMedCrossRefGoogle Scholar
  2. 2.
    S.J. Shattil, R. Anaya-Galindo, J. Bennet, R.W. Colman, R.A. Cooper, Platelet hypersensitivity induced by cholesterol incorporation. J. Clin. Invest. 55:636 (1975).PubMedCrossRefGoogle Scholar
  3. 3.
    G. Davi, M. Averna, F.P. Riolo, S. Novo, G. Mendola, M. Fiore, A. Strano, Increased thromboxane and malondialdehyde production by platelets from patients with hyperlipoproteinemia. In: VI Int. Cong, on Thrombosis of the Med. League against Thromboemb. Dis. Montecarlo, October 23–25 (1980).Google Scholar
  4. 4.
    D.E. Stevens, J.H. Joist, S.P. Sutera, Role of platelet-prosta-glandin synthesis in shear-induced platelet alterations. Blood 56:753 (1980).PubMedGoogle Scholar
  5. 5.
    G. Davi, S. Novo, F.P. Riolo, A. Pinto, G. Mendola, A. Mazzola, M. Fazio, Formazione di malondialdeide piastrinica in pa-zienti ipertesi sottoposti a prova da sforzo al cicloergo-metro. In: Atti del Congresso Nazionale di Cardiología, Firenze, Maggio 1980.Google Scholar
  6. 6.
    G. Baroldi, Coronary thrombosis: Facts and Beliefs. Am. Heart J. 91:683 (1976).PubMedCrossRefGoogle Scholar
  7. 7.
    A. Strano, G. Davi, S. Novo, G. Avellone, Trombosi coronarica ed infarto del miocardio. Min. Angiol. 4:103 (1979).Google Scholar
  8. 8.
    W.C. Roberts, I.M. Buja, The frequency and the significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: a study of 107 necropsy patients. Am. J. Med. 52:425 (1972).PubMedCrossRefGoogle Scholar
  9. 9.
    A.B. Chandler, I. Chapman, L.R. Erhardt, Coronary thrombosis in myocardial infarction: report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am. J. Cardiol. 34:823 (1974).PubMedCrossRefGoogle Scholar
  10. 10.
    J.W. Haerem, Myocardial lesions in sudden unexpected coronary death. Am. Heart. J. 90:562 (1975).PubMedCrossRefGoogle Scholar
  11. 11.
    H.R. Baumgartner, Platelet interaction with vascular structures. Thromb. Diath. Haemorrh. Suppl. 51:161 (1972).Google Scholar
  12. 12.
    S. Chaudhuri, Platelet adhesiveness in the assessment of ischaemic heart disease. Thromb. Res. 6:208 (1975).CrossRefGoogle Scholar
  13. 13.
    S.C. Sharma, H.N. Seth, Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in acute myocardial infarction. Brit. Heart. J. 40:526 (1978).PubMedCrossRefGoogle Scholar
  14. 14.
    K.K. Wu, J.C. Hoak, A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 2:924 (1974).PubMedCrossRefGoogle Scholar
  15. 15.
    G. Hornstra, F. Ten Hoor, The filtragometer: a new device for measuring platelet aggregation in venous blood of man. Thromb. Diath. Haemorrh. 34:531 (1975).PubMedGoogle Scholar
  16. 16.
    K.K. Wu, J.C. Hoak, Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications. Thromb. Haemost. 35:702 (1976).PubMedGoogle Scholar
  17. 17.
    R.C. Paton, H. Lee, A. Thomaidis, P. Passa, J. Caen, ADP-induced aggregation and fibrinogen binding in platelets from diabetic patients. In.: VI Int. Cong, on Thrombosis of the Med. League against Thromboemb. Dis. Montecarlo, October 23–25 (1980)Google Scholar
  18. 18.
    P. Mehta, J. Mehta, Platelet function studies in coronary heart disease: VIII. Decreased platelet sensitivity to prostacyclin in patients with myocardial ischaemia. Thromb. Res. 18:273 (1980).PubMedCrossRefGoogle Scholar
  19. 19.
    J. Gormsen, J.B. Knudsen, J.D. Nielsen, O. Amtorp, K. Skagen, Platelet function, coagulation, fibrinolysis, factor XIII and antithrombin III in acute transmural myocardial infarction. In: Proc. of Florence Int. Meet, on Myoc. Inf. May 8–12, 1979, p. 233, Excerpta Medica, Amsterdam-Oxford-Princeton (1979).Google Scholar
  20. 20.
    G. Davit, S. Novo, F.P. Riolo, G. Avellone, Platelet aggregation in subjects with ischemic heart disease. In: Strano, A. (ed.) Advances in Coagulation, Fibrinolysis, Platelet Aggregation and Atherosclerosis, p. 372, CEPI, Roma (1976).Google Scholar
  21. 21.
    P. Mehta, J. Mehta, Platelet function studies in coronary artery disease: Evidence for enhanced platelet microthrombus formation activity in acute myocardial infarction. Am. J. Cardiol. 43:757 (1979).PubMedCrossRefGoogle Scholar
  22. 22.
    A. Strano, S. Novo, G. Davi, G. Avellone, A. Pinto, Platelet aggregation, coagulation and fibrinolysis at rest and after bicycle ergometer test in CHD. In: Selected topics in exercise cardiology and rehabilitation (eds. A. Raineri, J.J. Kellermann, V. Rulli), Plenum Publishingn p. 265 (1980).CrossRefGoogle Scholar
  23. 23.
    G. Davì, M. Traina, S. Novo, V. Albano, G.L. Piraino, M.P. Muzzo, G. Marano, A. Raineri, A. Strano, Platelet function changes in acute myocardial infarction. In: II Eur. Symp. on Coagulation, Platelet Function, Fibrinolysis and Vascular Diseases, Palermo, 5–8 December 1980.Google Scholar
  24. 24.
    M.J. Stuart, S. Murphy, F.A. Oski, A simple non radioisotope technic for the determination of platelet life-span. New. Engl. J. Med. 292:1310 (1975).PubMedCrossRefGoogle Scholar
  25. 25.
    R. Roncucci, R. Deperon, J. Destailleur, J. Doumont, G. Lambelin J. Lansen, M. Moriau, F. Van Stalle, R. Vernaegher, Measurement of platelet regeneration time in cardiovascular patients. Thromb. Res. 14:3 (1979).PubMedCrossRefGoogle Scholar
  26. 26.
    S.K. Garg, E.L. Amorosi, S. Karpatkin, Use of megathrombocytes as an index of megakaryocyte number. New. Engl. J. Med. 284:11 (1971).PubMedCrossRefGoogle Scholar
  27. 27.
    P. Steele, J. Rainwater, R. Vogel, Abnormal platelet survival time in men with myocardial infarction and normal coronary arteriogram. Am. J. Cardiol. 41:60 (1978).PubMedCrossRefGoogle Scholar
  28. 28.
    G.G. Neri Serneri, G.F. Gensini, R. Abbate, D. Prisco, C. Mugnaini, Soluble fibrinogen complexes and platelet aggregates in patients with history of myocardial infarction and chronic cerebrovascular disorders. A rationale for prophylactic therapy. In: Strano A. (ed.): Advances in Coagulation, Fibrinolysis, Platelet Aggregation and Atherosclerosis, p. 227, CEPI, Roma (1976).Google Scholar
  29. 29.
    G. Davi, F.P. Riolo, S. Novo, A. Pinto, G. Mendola, M.P. Muzzo, M. Russotto, Malondialdehyde formation and Beta-thromboglo-bulin levels in patients with diabetes mellitus. In.: VI Int. Cong, on Thrombosis of the Med. League against Thromboemb. Dis. Montecarlo, October 23–25 (1980).Google Scholar
  30. 30.
    H.H. Salem, J. Koutts, B.G. Firkin, Circulating platelet aggregates in ischaemic heart disease and their correlation to platelet life span. Thromb. Res. 17:707 (1980).PubMedCrossRefGoogle Scholar
  31. 31.
    J. Zahavi, V.V. Kakkar, Beta-thromboglobulin — a specific marker of in vivo platelet release reaction. Thromb. Haemost. 44: 23 (1980).PubMedGoogle Scholar
  32. 32.
    S. Moore, D.S. Pepper, J.D. Cash, The isolation and characterisation of a platelet specific Beta-thromboglobulin and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets. Bioch. Biophys. Acta 379:360 (1975).CrossRefGoogle Scholar
  33. 33.
    C.A. Ludlam, S. Moore, A.E. Bolton, D.S. Pepper, J.D. Cash, The release of a human specific protein measured by a radioimmunoassay. Thromb. Res. 6:543 (1975).PubMedCrossRefGoogle Scholar
  34. 34.
    K. Gjesdal, Platelet factor 4: an electroimmunoassay for PF4 in human plasma. Scand. J. Haemat. 13:232 (1974).PubMedCrossRefGoogle Scholar
  35. 35.
    L.D. Witte, K.L. Kaplan, H.L. Nossel, B.A. Lages, H.J. Weiss, S.G. De Witt, Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ. Res. 42:402 (1978).PubMedCrossRefGoogle Scholar
  36. 36.
    J.R. O’Brien, Antithrombin III and heparin clotting times in thrombosis and atherosclerosis. Thromb. Diath. Haemorrh. 32:116 (1974).PubMedGoogle Scholar
  37. 37.
    G. Pearson, Plasma factors regulating prostaglandin biosynthesisand metabolism. In: Int. Symp. “Prostaglandins and the Cardio-vascular system”, Wiilrijk, December 1–3 (1980).Google Scholar
  38. 38.
    J. Zahavi, N.A.G. Jones, J. Leyton, M. Dubiel, V.V. Kakkar, Enhanced in vivo platelet release reaction in old healthy individuals. Thromb. Res. 17:329 (1980).PubMedCrossRefGoogle Scholar
  39. 39.
    R.M. Hardisty, R.A. Hutton, The kaolin clotting time of platelet-rich plasma. A test for platelet factor 3 availability. Br. J. Haemat. 11:258 (1965).CrossRefGoogle Scholar
  40. 40.
    R.D. Shuttleworth, J.R. O’Brien, Intraplatelet serotonin and plasma 5-hydroxyindoles in health and disease. In: VI Int. Cong, on Thrombosis of the Med. League against Thromboemb. Dis. Montecarlo, October 23–25 (1980).Google Scholar
  41. 41.
    P. Needleman, M. Minkes, A. Raz, Tromboxanes: selective biosynthesis and distinct biological properties. Science 193: 163 (1979).CrossRefGoogle Scholar
  42. 42.
    S. Moneada, J.R. Vane, Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br. Med. Bull. 34:129 (1978).Google Scholar
  43. 43.
    J.B. Smith, C. Ingerman, M.J. Silver, Persistance of thromboxane A2-like material and platelet release inducing activity in plasma. J. Clin. Invest. 58:1119 (1976).PubMedCrossRefGoogle Scholar
  44. 44.
    E.W. Salzman, J.N. Lindon, R. Rodvien, Cyclic AMP in human blood platelets VI. Relation to platelet prostaglandin synthesis induced by centrifugation or surface contact. J. Cyc. Nucl. Res. 2:25 (1976).Google Scholar
  45. 45.
    C. Malmsten, E. Gränstrom, B. Samuelsson, Cyclic AMP inhibits synthesis of prostaglandins endoperoxide in human platelets. Biochim. Biophys. Res. Commun. 68:596 (1976).Google Scholar
  46. 46.
    G. Davì, A. Pinto, S. Novo, F. Riolo, A. Strano, 6-keto PGF and TxB2 formation in patients with claudicatio intermittens before and after dipyridamole. In: Int. Symp. “Prostaglandins and the Cardiovascular System”, Wiilrijk, December 1–3 (1980).Google Scholar
  47. 47.
    E. Tremoli, G. Folco, E. Agradi, C. Galli, Platelet thromboxa nes and serum cholesterol. Lancet 1:107 (1979).PubMedCrossRefGoogle Scholar
  48. 48.
    E. Tremoli, P. Madema, C.R. Sirtori, Platelet aggregation and MDA formation in type IIa hypercholesterolemic patients. Haemostasis 8:47 (1979).PubMedGoogle Scholar
  49. 49.
    M.J. Stuart, J.M. Gerrard, J.G. White, Effect of cholesterol on production of thromboxane B2 by platelets in vitro. New. Engl. J. Med. 302:6 (1980).PubMedCrossRefGoogle Scholar
  50. 50.
    R. Gryglewski, A. Szczeklik, Prostaglandins and atherosclerosis. In: Int. Sym. “Prostaglandins and the Cardiovascular System”, Wiilrijk, December 1–3 (1980).Google Scholar
  51. 51.
    R.I. Lewy, B. Smith, M.J. Silver, J. Saia, P. Walinsky, L. Wiener, Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal’s angina. Prostaglandins and Medicine 5:243 (1979).CrossRefGoogle Scholar
  52. 52.
    J.B. Smith, Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation 61:1165 (1980).PubMedCrossRefGoogle Scholar
  53. 53.
    G.G. Neri Serneri, Aterosclerosi e stati trombofolici. Ed. Pozzŕ, Roma (1979), p. 93.Google Scholar
  54. 54.
    J.C. Hoak, G.L. Fry, R.L. Czervionke, J.B. Smith, Haemostatic changes associated with acute myocardial infarction. In: Proc. of Florence Int. Meet, on Myocardial Infarction, May 8–12, 1979, p.290, Excerpta Medica, Amsterdam-Oxford-Princeton, (1979).Google Scholar
  55. 55.
    A. Strano, S. Novo, G. Davì, Prevenzione farmacologica della trombosi. In: Atti del Corso Int. “Cardiología Preventiva”, Catanzaro 29 Settembre — 3 Ottobre 1977. Ed: Piccin, Padova, p. 209.Google Scholar
  56. 56.
    A. Strano, G. Davì, S. Novo, Gli antiaggreganti piastrinici nella prevenzione dell1infarto del miocardio. Giorn.Arte-rioscl. 2:58 (1978).Google Scholar
  57. 57.
    A. Strano, S. Novo, F.P. Riolo, Quando e come usare gli antiaggreganti e gli anticoagulanti in cardiologoa. In: Progressi in Cardiología, ed. Pozzi, Roma, p. 420 (1978).Google Scholar
  58. 58.
    A. Strano, S. Novo, Prospettive nell’impiego degli antiaggre-ganti nella prevenzione dell’arteriosclerosi. Giorn. It. Card. IX, I, I (1980).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • A. Strano
    • 1
  • G. Davì
    • 1
  1. 1.Institute of Clinical Medicine and Medical TherapyUniversity of PalermoPalermoItaly

Personalised recommendations